Comparison of the classic Glucksberg criteria and the IBMTR Severity Index for grading acute graft-versus-host disease following HLA-identical sibling stem cell transplantation. International Bone Marrow Transplant Registry
- PMID: 10455367
- DOI: 10.1038/sj.bmt.1701899
Comparison of the classic Glucksberg criteria and the IBMTR Severity Index for grading acute graft-versus-host disease following HLA-identical sibling stem cell transplantation. International Bone Marrow Transplant Registry
Abstract
Acute graft-versus-host disease (AGVHD) severity is usually graded (grades 0-IV) by the pattern of organ involvement using the classic Glucksberg-Seattle criteria (GSC). Recently, the International Bone Marrow Transplant Registry (IBMTR) developed a new Severity Index by regrouping the patterns of organ involvement into five Indexes (0-D) that appeared more predictive of transplant-related mortality (TRM) and transplant failure (TF, relapse or TRM). We studied the predictive value of both grading systems of TRM, TF and GVHD-related mortality (GTRM) in a series of 114 consecutive patients > or = 12 years old allografted from a histocompatible sibling at our institution, 100 of whom were evaluable for AGVHD. The IBMTR Severity Index showed better incremental prediction of TRM (relative risks (RR) of 1, 1.5, 1.4, 2 and 2.5 for Indexes 0, A, B, C and D), TF (RRs of 1, 1.6, 1.6, 2 and 2.3, respectively) and GTRM (RRs of 1, 2.2 and 4.8 for Indexes B, C and D) than the GSC. With the GSC different outcomes for TRM and TF were found only from grade 0 to I-II and 0 to IV or I-III to IV, but not from I-II to III. The GSC also appeared less predictive of GTRM (RRs of 1, 0.4 and 2.9 for grades II, III and IV). In our relatively small patient sample, the new IBMTR Severity Index appeared more predictive of transplant outcome than the GSC, especially between no AGVHD, early Indexes (A-B) and advanced Indexes (C-D).
Similar articles
-
Serum cholinesterase is an early and sensitive marker of graft-versus host-disease (GVHD) and transplant-related mortality (TRM).Bone Marrow Transplant. 2001 Dec;28(11):1041-5. doi: 10.1038/sj.bmt.1703281. Bone Marrow Transplant. 2001. PMID: 11781614
-
IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade.Br J Haematol. 1997 Jun;97(4):855-64. doi: 10.1046/j.1365-2141.1997.1112925.x. Br J Haematol. 1997. PMID: 9217189
-
The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation.Bone Marrow Transplant. 2001 May;27(9):949-58. doi: 10.1038/sj.bmt.1703027. Bone Marrow Transplant. 2001. PMID: 11436105
-
Nonmyeloablative allogeneic stem cell transplantation (NST) after truly nonmyeloablative and reduced intensity conditioning regimens.Crit Rev Oncol Hematol. 2004 Sep;51(3):171-89. doi: 10.1016/j.critrevonc.2004.05.008. Crit Rev Oncol Hematol. 2004. PMID: 15331077 Review.
-
1994 Consensus Conference on Acute GVHD Grading.Bone Marrow Transplant. 1995 Jun;15(6):825-8. Bone Marrow Transplant. 1995. PMID: 7581076 Review.
Cited by
-
Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years.Blood Adv. 2019 Oct 22;3(20):3070-3079. doi: 10.1182/bloodadvances.2019000480. Blood Adv. 2019. PMID: 31648330 Free PMC article.
-
Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome After Myeloablative Conditioning.Ther Drug Monit. 2015 Aug;37(4):493-500. doi: 10.1097/FTD.0000000000000180. Ther Drug Monit. 2015. PMID: 25565670 Free PMC article.
-
Sole Upfront Therapy with Beclomethasone and Budesonide for Upper Gastrointestinal Acute Graft-versus-Host Disease.Biol Blood Marrow Transplant. 2020 Jul;26(7):1303-1311. doi: 10.1016/j.bbmt.2020.04.023. Epub 2020 Apr 30. Biol Blood Marrow Transplant. 2020. PMID: 32361010 Free PMC article.
-
Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia.Leuk Lymphoma. 2009 Jan;50(1):85-91. doi: 10.1080/10428190802626624. Leuk Lymphoma. 2009. PMID: 19142796 Free PMC article.
-
A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality.Biol Blood Marrow Transplant. 2015 Apr;21(4):761-7. doi: 10.1016/j.bbmt.2015.01.001. Epub 2015 Jan 10. Biol Blood Marrow Transplant. 2015. PMID: 25585275 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous